Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

The symposium showed that stem cells are key for understanding and treating skin diseases and for developing new skin models and therapies.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Finasteride effectively treats hidradenitis suppurativa for most patients.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Dutasteride may protect the brain in early Parkinson's disease.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Accurate diagnosis of progressive supranuclear palsy requires thorough neurological assessments and MRI.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

JAK inhibitors show promise for treating various skin diseases.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.